In all, 36% of children treated with omalizumab (Xolair) for a year successfully ate full servings of allergy-triggering foods, according to phase 2 trial results. Adobe stock/HealthDay More than a ...
Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a potential treatment for obese people with the respiratory condition, who ...
Managing asthma often requires a two-pronged approach — long-term medicines to prevent attacks and rescue strategies to stop attacks when they happen. It’s important to avoid triggers and monitor ...
Scientists at Northwestern University in Chicago have found that a drug used for asthma could stop life-threatening food allergies by inhibiting a reaction in the first place. Scientists at ...
People taking GLP-1 medications had better-controlled asthma overall, though there was no difference in lung function compared to those not taking GLP-1s. The study suggests that GLP-1 drugs may have ...
Those trendy weight loss shots everyone’s talking about? Turns out they might do more than shrink your waistline — they could help you breathe easier too. New research involving 60,000 people just ...
Severe asthma is already treatable with a monthly injectable GSK drug, the blockbuster product Nucala. A new FDA approval gives the drugmaker the opportunity to reach patients with a different ...
A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...
Monthly injection with tezepelumab helped 90% of patients with severe asthma reduce intake of daily steroid tablets. The corresponding study was published in The Lancet Respiratory Medicine. “In this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results